Arcellx (ACLX) Cash & Equivalents (2021 - 2025)

Arcellx's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $80.3 million for Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 24.05% year-over-year to $80.3 million in Q4 2025; TTM through Dec 2025 was $80.3 million, a 24.05% decrease from a year earlier, with the FY2025 full-year figure at $80.3 million, down 24.05% from the prior year.
• Cash & Equivalents grew to $80.3 million in Q4 2025 per ACLX's latest filing, from $79.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $394.6 million in Q4 2023 and bottomed at $30.8 million in Q4 2021.
• The 5-year median for Cash & Equivalents is $111.7 million (2021), against an average of $134.9 million.
• Across the five-year window, Cash & Equivalents soared 514.82% in 2023 and plunged 73.22% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $30.8 million in 2021, then jumped by 108.15% to $64.2 million in 2022, then surged by 514.82% to $394.6 million in 2023, then plunged by 73.22% to $105.7 million in 2024, then retreated by 24.05% to $80.3 million in 2025.
• Per Business Quant, the three latest ACLX Cash & Equivalents figures stand at $80.3 million (Q4 2025), $79.0 million (Q3 2025), and $62.3 million (Q2 2025).